Strategic Partnership Enables Akari to Accelerate IND Filing By Late 2026 TAMPA, FL and LONDON – April 6, 2026 – Akari Therapeutics, Plc (Nasdaq: AKTX), an …
PRESS RELEASES
Akari Therapeutics Announces Abstract Accepted for Poster Presentation at the American Association for Cancer Research Annual Meeting 2026
TAMPA, FL and LONDON – March 18, 2026 – Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) …
Akari Therapeutics Announces ADS Ratio Change
TAMPA, FL and LONDON – March 17, 2026 – Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) …
[Read more...] about Akari Therapeutics Announces ADS Ratio Change
